| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.038 | 0.5 |